1,728 results match your criteria Giornale italiano di cardiologia 2006[Journal]


[Giant negative T waves on the electrocardiogram: what is underneath?]

G Ital Cardiol (Rome) 2019 Feb;20(2):120-121

Unità di Cardiologia, Ospedale "Madonna delle Grazie", Matera.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30860DOI Listing
February 2019

[Infero-postero-lateral acute myocardial infarction caused by left ventricular myxoma embolism].

G Ital Cardiol (Rome) 2019 Feb;20(2):117-119

Divisione di Cardiologia, Dipartimento di Medicina Interna, Ospedale Maria Vittoria, Torino.

The majority of myxomas are located in the left atrium (75%) followed by the right atrium (20%). In rare cases, myxomas can be found in the ventricles, with 2.5% reported for myxomas in the left ventricle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30859DOI Listing
February 2019
1 Read

[Surgical management of hypertrophic obstructive cardiomyopathy: the role of mitral valve].

G Ital Cardiol (Rome) 2019 Feb;20(2):109-116

Unità di Cardiochirurgia, Dipartimento per la Cura e lo Studio delle Patologie Cardiotoraciche e dei Trapianti Cardiotoracici, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo.

Hypertrophic obstructive cardiomyopathy (HOCM) is the most frequently inherited cardiovascular disease (prevalence in the general population of 1/500) and is characterized by significant left ventricular hypertrophy, especially in the interventricular septum, combined with small-volume cardiac cavities. Transaortic surgical septal myectomy is the most commonly used technique to treat HOCM, and is associated with low operative morbidity and mortality and a reduction of the outflow gradients. The composite operative mortality of only 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30858DOI Listing
February 2019

[Treatment of secondary ischemic mitral regurgitation: controversial issues].

G Ital Cardiol (Rome) 2019 Feb;20(2):97-108

Centro Cardiologico Universitario e LTTA Centre, Università degli Studi, Ferrara - Maria Cecilia Hospital, GVM Care & Research, E.S. Health Science Foundation, Cotignola (RA).

The presence of secondary mitral regurgitation is an unfavorable prognostic factor in patients with chronic ischemic heart disease. This type of regurgitation can be treated with medical therapy, cardiac resynchronization therapy, surgically or percutaneously but each strategy has controversial aspects. The purpose of this review is to discuss the most debated issues relative to the various modalities available to treat ischemic secondary mitral regurgitation, highlighting also future perspectives. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30857DOI Listing
February 2019
1 Read

[New therapeutic options for the treatment of tricuspid regurgitation].

G Ital Cardiol (Rome) 2019 Feb;20(2):85-96

Unità di Cardiologia Interventistica, IRCCS Ospedale San Raffaele, Milano.

Tricuspid regurgitation is a common finding in patients with left-sided heart disease with prognostic implications. In addition, isolated tricuspid valve surgery is associated with high mortality and is infrequently performed. Hence, a largely unmet clinical need exists and less invasive therapeutic options are emerging: multiple percutaneous therapies have been developed, including tricuspid valve repair or replacement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30856DOI Listing
February 2019

[Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke].

G Ital Cardiol (Rome) 2019 02;20(2):73-84

Cardiologia Pediatrica e dell'Età Evolutiva, Centro per il Trattamento del Cardiopatico Congenito Adulto, Policlinico S. Orsola-Malpighi, Università degli Studi, Bologna.

Treatment of patients with cryptogenic stroke and a patent foramen ovale (PFO) has always been a matter of discussion. A clear pathogenic relationship is difficult to demonstrate in most cases, also because of the high prevalence of a PFO in the general population (25-30%). Early randomized trials failed to demonstrate a superiority of PFO transcatheter closure with respect to medical therapy alone but more recent data, coming from new randomized trials, strongly suggest that PFO closure associated with antiplatelet therapy is more effective than antiplatelet therapy alone in preventing recurrent stroke, with no increased risk of major adverse cardiovascular events in the follow-up; only a higher incidence of atrial fibrillation has been reported after PFO closure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30855DOI Listing
February 2019
1 Read

[Generic medicinal products: if you know them, you do not avoid them].

G Ital Cardiol (Rome) 2019 Feb;20(2):66-72

U.O.C. Cardiologia, Ospedali dell'Ovest Vicentino, Azienda ULSS 8 Berica, Arzignano (VI).

Although equivalent (generic) medicinal products have been introduced in the Italian market since decades, Italy is still among the latest for prescription of equivalent medicinal products. Several reasons may explain this behavior such as a scant familiarity with equivalent medicinal products, a general skepticism toward "not branded-named" medications and an "indolent laziness" both by specialists and general practitioners. Yet, the wider use of the generic drug could: (i) save economical resources for the National and Regional Health Services and allow to allocate them in clinical research and development of new therapies; (ii) reduce the economic burden for the patients by saving the brand drug-related co-payments, especially if they are on polytherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30854DOI Listing
February 2019

[Aspirin in primary prevention: the ARRIVE, ASCEND and ASPREE aftermath].

Authors:
Stefano Urbinati

G Ital Cardiol (Rome) 2019 Feb;20(2):63-65

U.O.C. Cardiologia, Ospedale Bellaria, Bologna.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30853DOI Listing
February 2019

In questo numero.

Authors:

G Ital Cardiol (Rome) 2019 Feb;20(2)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30852DOI Listing
February 2019

[Palliative care in the cardiac setting: a consensus document of the Italian Society of Cardiology/Italian Society of Palliative Care (SIC/SICP)].

G Ital Cardiol (Rome) 2019 Jan;20(1):46-61

Presidente SIC, Struttura Cardiologica, Policlinico Universitario, Cagliari.

Palliative care is recognized as an approach that improves quality of life of patients and families facing life-threatening illnesses. This is achieved through prevention, early identification, assessment and treatment of symptoms and other psycho-social, spiritual and economic issues. Palliative care is not dependent on prognosis and can be delivered as "simultaneous care", together with disease-modifying treatments and adequate symptom relief. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3079.30720DOI Listing
January 2019
15 Reads

[Subcutaneous defibrillator implantation with ultrasound-guided serratus block using the two-incision technique: our experience].

G Ital Cardiol (Rome) 2019 Jan;20(1):41-45

U.O.C. Cardiologia-UTIC.

Background: The aim of this study was to report our experience with subcutaneous defibrillator (S-ICD) implantation.

Methods: At our hospital, 7 procedures of S-ICD implantation were performed; 4 of these with ultrasound-guided serratus anterior plane block (SAPB) and 3 with usual local anesthesia followed by sedation.

Results: Surgical operations were not burdened with peri- and postprocedural complications, with only one event of limited hematoma of the thoracic wall. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30719DOI Listing
January 2019
1 Read

[Leadless pacing: present and future of cardiac stimulation].

G Ital Cardiol (Rome) 2019 Jan;20(1):32-40

Dipartimento di Scienze Cardiovascolari, Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza Università di Roma, Roma.

Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30718DOI Listing
January 2019
2 Reads

[Lifestyle, risk factors and prevention of cancer: role of the cardiologist].

G Ital Cardiol (Rome) 2019 Jan;20(1):20-31

U.O. Riabilitazione, Humanitas Gavazzeni, Bergamo.

Although commonly thought of as two separate disease entities, cardiovascular diseases and cancer, the leading causes of death, possess various possible interactions, including a number of similar risk factors (e.g. obesity, diabetes, chronic inflammation). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30717DOI Listing
January 2019
2 Reads

[Clinical applications of cardiac magnetic resonance imaging: coronary heart disease, myocarditis, pericardial diseases, arrhythmias, valvular heart disease, congenital heart disease and cardiac masses].

G Ital Cardiol (Rome) 2019 Jan;20(1):8-19

Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo.

Cardiac magnetic resonance is an accurate and versatile tool for multiparametric morphologic and functional evaluation of the heart and great vessels, with a wide range of clinical applications: from acute and chronic ischemic heart disease to the assessment of the substrate of complex ventricular arrhythmias and the follow-up of patients with valvular and congenital heart disease. The accuracy in cardiac volume and ejection fraction quantification, tissue characterization, valvular regurgitant fraction and cardiac shunt assessment, pharmachologic stress myocardial perfusion and three-dimensional reconstruction of great vessels are the points of strength that have made Cardiac magnetic resonance an invaluable tool for diagnostic, classification and follow-up of patients with various cardiac diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30716DOI Listing
January 2019
2 Reads

[Five questions for the clinician after the publication of the COMPASS trial].

Authors:
Leonardo De Luca

G Ital Cardiol (Rome) 2019 Jan;20(1):1-7

U.O.C. Cardiologia, Ospedale San Giovanni Evangelista, Tivoli (RM).

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3079.30715DOI Listing
January 2019
7 Reads

In questo numero.

Authors:

G Ital Cardiol (Rome) 2019 Jan;20(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30714DOI Listing
January 2019
1 Read

[When a purely observational approach does not provide reliable evidence].

G Ital Cardiol (Rome) 2018 Dec;19(12):727-728

Centro Studi ANMCO, Fondazione per il Tuo cuore - HCF onlus, Firenze.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30258DOI Listing
December 2018
1 Read

[Intravascular ultrasound-guided antegrade recanalization of a complex chronic total occlusion of the left anterior descending coronary artery: a case report].

G Ital Cardiol (Rome) 2018 Dec;19(12):724-726

U.O.C. Cardiologia Interventistica-UTIC, Ospedale Santo Spirito, Pescara.

Patients with coronary chronic total occlusion (CTO) if symptomatic for angina or with extensive inducible ischemia at provocative tests may be revascularized percutaneously or surgically. Percutaneous revascularization can be performed by antegrade or retrograde approach. In our case, in the presence of a long CTO of the left anterior descending coronary artery, the antegrade approach was chosen using an intravascular ultrasound (IVUS) catheter positioned in a secondary branch, to accurately identify the proximal lesion cap. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30257DOI Listing
December 2018
6 Reads

[Regional network for ST-elevation myocardial infarction in Italy: from development to management].

G Ital Cardiol (Rome) 2018 Dec;19(12):721-723

U.O.C. Cardiologia, Ospedale Maggiore, Bologna.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30256DOI Listing
December 2018
2 Reads

[The second multicenter observational registry on the management of acute ST-elevation myocardial infarction in the Veneto Region (VENERE 2)].

Authors:

G Ital Cardiol (Rome) 2018 Dec;19(12):714-720

Background: We sought to evaluate the epidemiology and the management of ST-elevation acute myocardial infarction (STEMI) in the Veneto Region (VENERE 2) in 2014, 10 years after a similar survey conducted in the early 2000s.

Methods: Between October 2014 and March 2015, all consecutive patients admitted to the Cardiology Divisions of the Veneto Region with STEMI were enrolled in an observational, prospective, multicenter register, called VENERE 2. The main diagnostic and therapeutic efficiency indicators were analyzed and compared with data from the previous VENERE study performed 10 years earlier. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30255DOI Listing
December 2018
4 Reads

[The coronary sinus Reducer: a new opportunity for refractory angina. Comparison between Italian experiences].

G Ital Cardiol (Rome) 2018 Dec;19(12):705-713

Divisione di Cardiologia Interventistica, Dipartimento Cardio-Toraco-Vascolare, Istituto Scientifico San Raffaele, Milano.

Refractory angina is a disabling condition that afflicts patients in whom we have no more strategy to improve their quality of life. This phenomenon has been increasing over the last years due to longer life expectancy, also resulting in a significant impact upon healthcare resources. The coronary sinus Reducer is a novel technology designed to improve the quality of life of these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30254DOI Listing
December 2018
3 Reads

[Usefulness, timing and modality of ECG stress testing after myocardial revascularization].

G Ital Cardiol (Rome) 2018 Dec;19(12):692-704

Istituto di Cardiologia, Università degli Studi, Pisa.

Myocardial revascularization in patients with stable ischemic heart disease aims at eliminating myocardial ischemia, in order to (i) relieve anginal symptoms; (ii) improve functional capacity; and, possibly, (iii) improve prognosis. Given that ischemic recurrences are relatively common in patients undergoing myocardial revascularization, an appropriate follow-up is needed as part of a secondary prevention program. Stress testing can be here useful to: (i) detect residual or recurrent ischemia/angina; (ii) define functional capacity in order to establish physical aerobic training individualized programs; (iii) stratify prognosis. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3027.30253DOI Listing
December 2018
15 Reads

[Clinical applications of cardiac magnetic resonance imaging: heart failure and cardiomyopathies].

G Ital Cardiol (Rome) 2018 Dec;19(12):679-691

Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo.

Cardiac magnetic resonance (CMR) has proved to be a powerful tool in the assessment of several cardiac diseases, thanks to its capability to offer multiparametric morphologic and functional evaluation of the heart and great vessels, using neither ionizing radiations nor nephrotoxic contrast medium. The accuracy in quantification of cardiac volumes and ejection fraction (gold standard) together with native and post-contrast myocardial tissue characterization have made CMR an invaluable tool for the diagnosis, prognosis and therapeutic planning in patients with heart failure and cardiomyopathy. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3027.30252DOI Listing
December 2018
14 Reads

[Do not prescribe or defer treatment: when doing less could be better for the patient].

Authors:
Marco Bobbio

G Ital Cardiol (Rome) 2018 Dec;19(12):676-678

già Direttore S.C. Cardiologia, A.O. Santa Croce e Carle, Cuneo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30251DOI Listing
December 2018
1 Read

[The CULPRIT-SHOCK trial].

G Ital Cardiol (Rome) 2018 Dec;19(12):672-675

U.O.C. Cardiologia, Ospedale G.B. Morgagni, Forlì - Fondazione Cardiologica "Myriam Zito Sacco", Forlì.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30250DOI Listing
December 2018
2 Reads

[What's new in the 2018 ESC guidelines for the diagnosis and management of syncope?]

G Ital Cardiol (Rome) 2018 Dec;19(12):668-671

Dipartimento di Cardiologia, Centro Aritmologico, Ospedali del Tigullio, Lavagna (GE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30249DOI Listing
December 2018
2 Reads

[Journey around the heart in the movies of the last century: from Charlie Chaplin to the present day].

Authors:
Andrea Pozzati

G Ital Cardiol (Rome) 2018 Dec;19(12):664-667

U.O.S. Cardiologia, Ospedale Dossetti di Bazzano (BO), AUSL di Bologna.

Imagine a journey through the cinema's history to recover the figure of the doctor in the last century. At the same time, we have found that the progress of medicine has conditioned the stories told on the big screen. Cardiology has achieved a leading role at the cinema when technological innovations have begun to emerge, from the '60s onwards. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30248DOI Listing
December 2018
4 Reads

[Giornale Italiano di Cardiologia Supplements and the Editor's role].

G Ital Cardiol (Rome) 2018 Dec;19(12):661-663

Editor, Giornale Italiano di Cardiologia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30247DOI Listing
December 2018
1 Read

In questo numero.

Authors:

G Ital Cardiol (Rome) 2018 Dec;19(12)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30246DOI Listing
December 2018
1 Read

[The hybrid strategy for complete myocardial revascularization in the frail elderly patient].

G Ital Cardiol (Rome) 2018 Nov;19(11):33-38

U.O.C. Cardiologia, Ospedale Belcolle, Viterbo.

The hybrid strategy allows for a complete myocardial revascularization in patients with multivessel coronary artery disease and a high frailty index. These patients, due to their old age and multi-comorbidities, are evaluated with inadequate tools for their clinical complexity and destined to an incomplete revascularization for increased surgical or procedural risk. Hybrid revascularization enables to use the best techniques resulting from the surgical and percutaneous approach defining a tailored strategy for the patient. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3019.30160DOI Listing
November 2018
11 Reads

[Tips and tricks: how to do a good coronary angioplasty? Instructions for use].

G Ital Cardiol (Rome) 2018 Nov;19(11):22-32

Unità di Cardiologia interventistica, Ospedale San Raffaele, Milano.

Percutaneous coronary angioplasty celebrated its 40th anniversary and gained an established role thanks to its remarkable results. The progressive development of techniques and materials together with a better understanding about the pharmacological treatment of patients with coronary artery disease contributed to this success. Nowadays percutaneous treatments have become a valid alternative to coronary artery bypass graft surgery in many patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30159DOI Listing
November 2018
2 Reads

[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost never].

G Ital Cardiol (Rome) 2018 Nov;19(11):18-21

Divisione di Cardiologia, Centro Alte Specialità e Trapianti (CAST), Ospedale Policlinico Gaspare Rodolico, Università degli Studi, Catania.

The expansion of the options for the treatment of patients with stable multivessel coronary artery disease (CAD), including medical therapy or myocardial revascularization by a surgical or a percutaneous strategy, has raised the need to set the decision-making process to select the optimal therapy on a multidisciplinary approach. Indeed, this latter would potentially lead to identify the most appropriate strategy for a given patient in the most transparent, shared and comprehensive way as possible. The multidisciplinary approach has been widely encouraged in the cardiovascular field, where it has been defined as "Heart Team" (HT), a collegial system essentially including a cardiac surgeon, a clinical cardiologist and an interventionalist. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30158DOI Listing
November 2018
4 Reads

[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost every time].

Authors:
Lucia Torracca

G Ital Cardiol (Rome) 2018 Nov;19(11):14-17

U.O. Cardiochirurgia, Humanitas Research Hospital, Rozzano (MI).

The multidisciplinary discussion is a well-established method, highly widespread in different medical disciplines, with documented optimal results. This practice, despite mandate by international guidelines, is not universally applied to guide treatment in coronary artery disease (CAD) patients. The literature provides data both on overtreatment or undertreatment in different patient subsets, clearly suggesting its strong need. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3019.30157DOI Listing
November 2018
8 Reads

[Is angioplasty in patients with stable coronary artery disease only a placebo? Absolutely not].

G Ital Cardiol (Rome) 2018 Nov;19(11):12-13

SOD Interventistica Cardiologica Strutturale, AOU Careggi, Firenze.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30156DOI Listing
November 2018
1 Read

[Revascularization in stable coronary artery disease: what does the future hold after the ORBITA trial?]

Authors:
Rasha Al-Lamee

G Ital Cardiol (Rome) 2018 Nov;19(11):10-11

Imperial College London, Londra, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30155DOI Listing
November 2018
1 Read

[What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization?]

G Ital Cardiol (Rome) 2018 Nov;19(11):5-9

Klinik für Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Germania.

A revised version of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS) guidelines on myocardial revascularization has recently been published. These guidelines represent the third time that the ESC and EACTS have brought together cardiologists and cardiac surgeons in a joint Task Force to review the available evidence, with the mission of drafting balanced, patient-oriented, clinical practice guidelines on myocardial revascularization. During the last 4 years, a large body of evidence has become available and brought substantial changes to the guidelines. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30154DOI Listing
November 2018
4 Reads

[Presentation].

Authors:
Chiara Fraccaro

G Ital Cardiol (Rome) 2018 Nov;19(11):3-4

Deputy Editor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3019.30153DOI Listing
November 2018
1 Read

[Prof. Eligio Piccolo].

Authors:
Pietro Delise

G Ital Cardiol (Rome) 2018 Nov;19(11):658-659

U.O. Cardiologia Ospedale P. Pederzoli Peschiera del Garda (VR) e-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30114DOI Listing
November 2018
1 Read

[Hypokinetic cardiac arrest and hypereosinophilia: a case of Kounis or Churg-Strauss syndrome?]

G Ital Cardiol (Rome) 2018 Nov;19(11):655-657

Cardiologia, Ospedale S. Maria della Misericordia, Perugia.

Ischemic heart disease can be caused by multiple factors. However, epidemiological studies have evidenced an association between hypereosinophilia and acute coronary syndrome, most frequently observed in the Kounis and Churg-Strauss syndromes. We here report the case of a 37-year-old man, who was admitted to our hospital for acute coronary syndrome, complicated by hypokinetic cardiac arrest with severe hypereosinophilia. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30113DOI Listing
November 2018
10 Reads

[Inverse association between mortality and estimated functional capacity in hypertensive male outpatients with established coronary artery disease].

G Ital Cardiol (Rome) 2018 Nov;19(11):648-654

Centro Studi Biomedici Applicati allo Sport, Università degli Studi, Ferrara - Dipartimento Sanità Pubblica, AUSL Ferrara.

Background: Exercise capacity has been inversely associated with the incidence and severity of hypertension and cardiovascular disease. Cardiopulmonary exercise testing (CPET) is the gold standard for the determination of exercise capacity (i.e. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30112DOI Listing
November 2018
2 Reads

[Therapeutic strategies in elderly patients with acute coronary syndromes].

G Ital Cardiol (Rome) 2018 Nov;19(11):640-647

Dipartimento Cardiovascolare, Ospedale Alessandro Manzoni, Lecco.

Because of the aging of the population, the proportion of elderly patients admitted to the coronary care unit for an acute coronary syndrome (ACS) is increasing. Until a decade ago, treatment of elderly patients was based on poor scientific evidence, as older patients were commonly excluded from randomized controlled trials. In the last years, real-world registries and randomized controlled trials specifically addressing the older population have been published and provided clear evidence. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30111DOI Listing
November 2018
12 Reads

[Bleeding risk in patients with acute coronary syndromes treated with antiplatelet agents: incidence, prognosis and clinical evaluation. From research to clinical practice].

G Ital Cardiol (Rome) 2018 Nov;19(11):628-639

S.C. Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia.

Dual antiplatelet therapy (DAPT) including aspirin and a P2Y12 inhibitor is the cornerstone for the treatment of patients with acute coronary syndrome (ACS). The introduction of more potent drugs significantly reduced ischemic events, but with an associated increased risk of bleeding. Although appropriate estimation of bleeding risk by comparing the single drugs is challenging, mainly because of differences in definitions, it has been consistently shown that bleeding events are associated with an adverse outcome, both at short and long-term follow-up. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30110DOI Listing
November 2018
9 Reads

[Influenza infection and risk of myocardial infarction: the protective effect of influenza vaccination. One more reason to vaccinate].

G Ital Cardiol (Rome) 2018 Nov;19(11):620-627

U.O. Cardiologia, Ospedale Maggiore, Bologna.

Influenza infection, although considered a relatively benign pathology, is associated with a high number of hospital admissions and significant mortality, especially for the most vulnerable subjects. There is a great deal of evidence regarding the existence of an association between influenza and occurrence of cardiovascular events. Influenza vaccination by reducing the transmission of infection aims to reduce its complications, including cardiovascular events. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3012.30109DOI Listing
November 2018
8 Reads

[Heart transplantation: from the pioneering era to future prospects].

G Ital Cardiol (Rome) 2018 Nov;19(11):606-610

U.O.C. Cardiochirurgia e Centro Trapianti di Cuore, Ospedale San Camillo-Forlanini, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30107DOI Listing
November 2018
4 Reads

[70th Anniversary of the Framingham Heart Study. Cardiovascular epidemiology from the past to the future].

G Ital Cardiol (Rome) 2018 Nov;19(11):601-605

Dipartimento Malattie Cardiovascolari, Dismetaboliche e dell'Invecchiamento, Istituto Superiore di Sanità, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30106DOI Listing
November 2018
2 Reads

In questo numero.

Authors:

G Ital Cardiol (Rome) 2018 Nov;19(11)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3012.30105DOI Listing
November 2018
1 Read

[Treatment adherence in cardiovascular prevention].

G Ital Cardiol (Rome) 2018 Oct;19(10):41-56

U.O. Cardiologia Riabilitativa, Dipartimento di Cardioangiologia, Istituti Clinici Scientifici Maugeri, IRCCS di Pavia.

Treatment adherence is a key element for (i) improving prognosis in cardiovascular and/or high-risk patients, (ii) reducing the burden of morbidity and mortality associated with cardiovascular disease at a population level, and (iii) decreasing costs due to rehospitalizations.Promotion of adherence should embrace all pharmacological and non-pharmacological interventions in cardiovascular prevention, including lifestyle and behavioral changes. In this perspective, cardiac prevention and rehabilitation programs are the most appropriate and cost-effective setting for delivering structured and multi-component interventions on patient's adherence. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3001.30011DOI Listing
October 2018
15 Reads